TER•November 11, 2026 at 5:14 PM UTCSemiconductors & Semiconductor Equipment

Jefferies Nvidia Call Lifts Teradyne, but Valuation and Timing Risks Persist

Read source article

What happened

Teradyne shares jumped after Jefferies highlighted a potential $2 billion AI chip-testing opportunity tied to a growing Nvidia relationship. The note reinforces the company's status as a leveraged AI infrastructure beneficiary but arrives when the stock already trades at 49.6x trailing earnings and 73.8x EV/EBITDA. Meanwhile, Q3 guidance of $1.20B-$1.30B implies a sequential revenue decline and operating margin has compressed from 36.9% to 32.9% over two quarters. The Jefferies estimate is not confirmed backlog and rests on assumptions about Nvidia's future tester needs that may take years to materialize. As a result, the stock's reaction is understandable but does not alter the WAIT rating until concrete order evidence or a better valuation entry appears.

Implication

The Jefferies note adds credence to the AI test durability story but remains a sell-side estimate rather than contracted demand, so treat it as a sentiment catalyst rather than a fundamental upgrade. Current valuation assumes sustained above-cycle AI demand and does not discount execution risk from concentrated customers or export controls. The next two quarterly reports must show Semiconductor Test revenue holding near record levels, memory revenue above $200 million, and operating margin recovering above 35% to justify incremental upside. Until then, position sizing should reflect the high multiple and timing sensitivity: consider adding only below $315 or on evidence of margin re-expansion, while trimming above $425. A stricter stance is warranted if Q3 revenue lands below guidance or if major customers signal AI capex reductions.

Thesis delta

The WAIT rating is unchanged, as rich valuation and near-term revenue/margin softness remain the dominant constraints. However, the Jefferies $2 billion Nvidia opportunity raises the probability of durable AI-driven revenue into 2027, modestly lifting the bull-case value but not enough to warrant a rating upgrade without confirmed orders and margin recovery.

Confidence

Medium